Luis Enjuanes

Luis Enjuanes's AcademicInfluence.com Rankings

Luis Enjuanes

Biology

#12495

World Rank

#15973

Historical Rank

Virology

#303

World Rank

#310

Historical Rank

Genetics

#1376

World Rank

#1478

Historical Rank

Molecular Biology

#2036

World Rank

#2068

Historical Rank

biology Degrees

Download Badge

Biology

Luis Enjuanes's Degrees

PhD Biochemistry University of Valencia

Why Is Luis Enjuanes Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Luis Enjuanes's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group (2013) (1101)
Nidovirales: Evolving the largest RNA virus genome (2006) (805)
African swine fever virus (2005) (520)
Continuous and Discontinuous RNA Synthesis in Coronaviruses. (2015) (452)
Rapid generation of a mouse model for Middle East respiratory syndrome (2014) (419)
Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis (2014) (419)
Severe acute respiratory syndrome Coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3‐dependent ubiquitination of ASC (2019) (366)
Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome (2015) (366)
A Severe Acute Respiratory Syndrome Coronavirus That Lacks the E Gene Is Attenuated In Vitro and In Vivo (2006) (363)
A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae (2003) (356)
Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. (2000) (354)
Inhibition of NF-κB-Mediated Inflammation in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice Increases Survival (2013) (333)
Engineering a Replication-Competent, Propagation-Defective Middle East Respiratory Syndrome Coronavirus as a Vaccine Candidate (2013) (246)
Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis (2018) (224)
Sequence Motifs Involved in the Regulation of Discontinuous Coronavirus Subgenomic RNA Synthesis (2004) (223)
Targeted Recombination Demonstrates that the Spike Gene of Transmissible Gastroenteritis Coronavirus Is a Determinant of Its Enteric Tropism and Virulence (1999) (216)
Titration of African swine fever (ASF) virus. (1976) (212)
Biochemical aspects of coronavirus replication and virus-host interaction. (2006) (212)
Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein (2011) (209)
Construction of a Severe Acute Respiratory Syndrome Coronavirus Infectious cDNA Clone and a Replicon To Study Coronavirus RNA Synthesis (2006) (194)
Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Regulates Cell Stress Response and Apoptosis (2011) (190)
Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19 (2020) (190)
The PDZ-Binding Motif of Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Is a Determinant of Viral Pathogenesis (2014) (189)
The Nucleoprotein Is Required for Efficient Coronavirus Genome Replication (2004) (188)
Critical epitopes in transmissible gastroenteritis virus neutralization. (1986) (179)
Severe Acute Respiratory Syndrome Coronavirus nsp1 Facilitates Efficient Propagation in Cells through a Specific Translational Shutoff of Host mRNA (2012) (172)
Genetic evolution and tropism of transmissible gastroenteritis coronaviruses (1992) (170)
Structural Bases of Coronavirus Attachment to Host Aminopeptidase N and Its Inhibition by Neutralizing Antibodies (2012) (166)
Generation of a Replication-Competent, Propagation-Deficient Virus Vector Based on the Transmissible Gastroenteritis Coronavirus Genome (2002) (166)
Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids (2012) (164)
Two Amino Acid Changes at the N-Terminus of Transmissible Gastroenteritis Coronavirus Spike Protein Result in the Loss of Enteric Tropism (1997) (162)
Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice (2008) (162)
The Membrane M Protein Carboxy Terminus Binds to Transmissible Gastroenteritis Coronavirus Core and Contributes to Core Stability (2001) (160)
Coronavirus Nucleocapsid Protein Facilitates Template Switching and Is Required for Efficient Transcription (2009) (160)
Antigenic homology among coronaviruses related to transmissible gastroenteritis virus (1990) (156)
Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses (2016) (154)
Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity (1996) (144)
Coronavirus virulence genes with main focus on SARS-CoV envelope gene (2014) (144)
The transmissible gastroenteritis coronavirus contains a spherical core shell consisting of M and N proteins (1996) (142)
The SARS Coronavirus: A Postgenomic Era (2003) (133)
Genome-Wide Analysis of Protein-Protein Interactions and Involvement of Viral Proteins in SARS-CoV Replication (2008) (131)
Residues involved in the antigenic sites of transmissible gastroenteritis coronavirus S glycoprotein (1991) (129)
Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease (2010) (127)
Molecular Basis of Coronavirus Virulence and Vaccine Development (2016) (126)
Recombinant Canine Coronaviruses Related to Transmissible Gastroenteritis Virus of Swine Are Circulating in Dogs (2008) (125)
Coronavirus nucleocapsid protein is an RNA chaperone (2006) (123)
Coronavirus Gene 7 Counteracts Host Defenses and Modulates Virus Virulence (2011) (119)
Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine (2015) (119)
A Live Attenuated Severe Acute Respiratory Syndrome Coronavirus Is Immunogenic and Efficacious in Golden Syrian Hamsters (2008) (118)
Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease. (1987) (118)
Absence of E protein arrests transmissible gastroenteritis coronavirus maturation in the secretory pathway (2007) (115)
Transmissible gastroenteritis coronavirus gene 7 is not essential but influences in vivo virus replication and virulence (2003) (114)
Role of Nucleotides Immediately Flanking the Transcription-Regulating Sequence Core in Coronavirus Subgenomic mRNA Synthesis (2005) (114)
Severe Acute Respiratory Syndrome Coronaviruses with Mutations in the E Protein Are Attenuated and Promising Vaccine Candidates (2015) (113)
Monoclonal antibodies specific for African swine fever virus proteins (1985) (113)
Complete Protection against Severe Acute Respiratory Syndrome Coronavirus-Mediated Lethal Respiratory Disease in Aged Mice by Immunization with a Mouse-Adapted Virus Lacking E Protein (2013) (112)
A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies (2021) (112)
Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease (2007) (112)
RNA-RNA and RNA-protein interactions in coronavirus replication and transcription (2011) (110)
Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C. (1988) (106)
Adaptive Evolution of MERS-CoV to Species Variation in DPP4 (2018) (105)
MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection (2018) (103)
Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein (2019) (102)
Severe Acute Respiratory Syndrome Coronavirus Replication Inhibitor That Interferes with the Nucleic Acid Unwinding of the Viral Helicase (2012) (99)
A G-quadruplex-binding macrodomain within the “SARS-unique domain” is essential for the activity of the SARS-coronavirus replication–transcription complex (2015) (97)
Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus (1988) (97)
Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication (2011) (95)
Coronavirus reverse genetic systems: Infectious clones and replicons (2014) (95)
Specific Secretion of Active Single-Chain Fv Antibodies into the Supernatants of Escherichia coliCultures by Use of the Hemolysin System (2000) (94)
Mutagenesis of Coronavirus nsp14 Reveals Its Potential Role in Modulation of the Innate Immune Response (2016) (90)
Subcellular localization of the severe acute respiratory syndrome coronavirus nucleocapsid protein. (2005) (88)
Engineering the Transmissible Gastroenteritis Virus Genome as an Expression Vector Inducing Lactogenic Immunity (2003) (88)
Recommendations of the coronavirus study group for the nomenclature of the structural proteins, mRNAs, and genes of coronaviruses (1990) (87)
Antigenic differentiation between transmissible gastroenteritis virus of swine and a related porcine respiratory coronavirus. (1988) (87)
Transcription Regulatory Sequences and mRNA Expression Levels in the Coronavirus Transmissible Gastroenteritis Virus (2002) (86)
Recovery of a Neurovirulent Human Coronavirus OC43 from an Infectious cDNA Clone (2006) (81)
Engineering passive immunity in transgenic mice secreting virus-neutralizing antibodies in milk (1998) (80)
Replication and Packaging of Transmissible Gastroenteritis Coronavirus-Derived Synthetic Minigenomes (1999) (80)
Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus (1996) (78)
SARS-CoV-Encoded Small RNAs Contribute to Infection-Associated Lung Pathology (2017) (76)
Complete Genome Sequence of Transmissible Gastroenteritis Coronavirus PUR46-MAD Clone and Evolution of the Purdue Virus Cluster (2004) (76)
Monoclonal antibodies of African swine fever virus: antigenic differences among field virus isolates and viruses passaged in cell culture (1986) (75)
Analysis of SARS-CoV E protein ion channel activity by tuning the protein and lipid charge (2013) (75)
Organization of Two Transmissible Gastroenteritis Coronavirus Membrane Protein Topologies within the Virion and Core (2001) (74)
Molecular Basis of Transmissible Gastroenteritis Virus Epidemiology (1995) (74)
Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus. (1990) (72)
Stabilization of a Full-Length Infectious cDNA Clone of Transmissible Gastroenteritis Coronavirus by Insertion of an Intron (2002) (71)
Membrane protein molecules of transmissible gastroenteritis coronavirus also expose the carboxy-terminal region on the external surface of the virion (1995) (70)
Host cell proteins interacting with the 3′ end of TGEV coronavirus genome influence virus replication (2009) (70)
The Polypyrimidine Tract-Binding Protein Affects Coronavirus RNA Accumulation Levels and Relocalizes Viral RNAs to Novel Cytoplasmic Domains Different from Replication-Transcription Sites (2011) (70)
Cross-links in African swine fever virus DNA (1979) (69)
Relevance of Viroporin Ion Channel Activity on Viral Replication and Pathogenesis (2015) (68)
Molecular Characterization of Transmissible Gastroenteritis Coronavirus Defective Interfering Genomes: Packaging and Heterogeneity (1996) (68)
Isolation and properties of the DNA of African swine fever (ASF) virus. (1976) (64)
Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection (2018) (64)
Development of a transgenic mouse model susceptible to human coronavirus 229E. (2005) (63)
Identification of a Coronavirus Transcription Enhancer (2008) (62)
Phosphorylation and subcellular localization of transmissible gastroenteritis virus nucleocapsid protein in infected cells. (2005) (62)
Characterization of the sialic acid binding activity of transmissible gastroenteritis coronavirus by analysis of haemagglutination-deficient mutants. (2000) (62)
Transmissible Gastroenteritis Coronavirus Packaging Signal Is Located at the 5′ End of the Virus Genome (2003) (60)
Mechanisms of transmissible gastroenteritis coronavirus neutralization (1990) (60)
Porcine leukocyte cellular subsets sensitive to African swine fever virus in vitro (1984) (60)
Molecular Characterization of Feline Infectious Peritonitis Virus Strain DF-2 and Studies of the Role of ORF3abc in Viral Cell Tropism (2012) (60)
Transgenic Mice Secreting Coronavirus Neutralizing Antibodies into the Milk (1998) (57)
The use of transient expression systems for the rapid production of virus-like particles in plants. (2013) (56)
The envelope protein of severe acute respiratory syndrome coronavirus interacts with the non-structural protein 3 and is ubiquitinated (2010) (55)
A Novel Sorting Signal for Intracellular Localization Is Present in the S Protein of a Porcine Coronavirus but Absent from Severe Acute Respiratory Syndrome-associated Coronavirus* (2004) (54)
Role of RNA chaperones in virus replication (2008) (54)
Binding of Transmissible Gastroenteritis Coronavirus to Cell Surface Sialoglycoproteins (2002) (53)
A novel porcine reproductive and respiratory syndrome virus vector system that stably expresses enhanced green fluorescent protein as a separate transcription unit (2013) (52)
Coronavirus Replication and Reverse Genetics (2005) (49)
Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread. (2012) (49)
Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus (1990) (47)
Coronavirus derived expression systems (2001) (46)
Alphacoronavirus Protein 7 Modulates Host Innate Immune Response (2013) (46)
Severe Acute Respiratory Syndrome Coronavirus Protein 6 Is Required for Optimal Replication (2008) (45)
Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex. (1979) (45)
Virology. The SARS coronavirus: a postgenomic era. (2003) (45)
Development of Protection against Coronavirus Induced Diseases (1995) (44)
Localization of structural proteins in African swine fever virus particles by immunoelectron microscopy (1986) (44)
Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies (1996) (43)
Sensitivity of macrophages from different species to African swine fever (ASF) virus. (1977) (42)
Vectored vaccines to protect against PRRSV (2010) (42)
Induction of Antibodies Protecting against Transmissible Gastroenteritis Coronavirus (TGEV) by Recombinant Adenovirus Expressing TGEV Spike Protein (1995) (42)
Two Types of Virus-Related Particles Are Found during Transmissible Gastroenteritis Virus Morphogenesis (1998) (41)
An antibody derivative expressed from viral vectors passively immunizes pigs against transmissible gastroenteritis virus infection when supplied orally in crude plant extracts (2006) (40)
Epitope specificity of protective lactogenic immunity against swine transmissible gastroenteritis virus (1992) (40)
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19 (2022) (37)
The sialic acid binding activity of the S protein facilitates infection by porcine transmissible gastroenteritis coronavirus (2011) (37)
Structure and Functional Relevance of a Transcription-Regulating Sequence Involved in Coronavirus Discontinuous RNA Synthesis (2011) (36)
Porcine aminopeptidase N mediated polarized infection by porcine epidemic diarrhea virus in target cells (2015) (35)
Lack of protection in vivo with neutralizing monoclonal antibodies to transmissible gastroenteritis virus (1988) (34)
A Transmissible Gastroenteritis Coronavirus Nucleoprotein Epitope Elicits T Helper Cells That Collaborate in the in Vitro Antibody Synthesis to the Three Major Structural Viral Proteins (1995) (33)
An adenovirus recombinant expressing the spike glycoprotein of porcine respiratory coronavirus is immunogenic in swine. (1996) (33)
Development of a novel DNA-launched dengue virus type 2 infectious clone assembled in a bacterial artificial chromosome (2013) (33)
Interference of coronavirus infection by expression of immunoglobulin G (IgG) or IgA virus-neutralizing antibodies (1997) (32)
Development of protection against coronavirus induced diseases. A review. (1995) (32)
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins (2020) (31)
Antigen selection and presentation to protect against transmissible gastroenteritis coronavirus (1992) (31)
Coronavirus Reverse Genetics and Development of Vectors for Gene Expression (2005) (30)
Comparison of vesicular stomatitis virus pseudotyped with the S proteins from a porcine and a human coronavirus. (2009) (30)
Long-Distance RNA-RNA Interactions in the Coronavirus Genome Form High-Order Structures Promoting Discontinuous RNA Synthesis during Transcription (2012) (29)
Antigenic structure of transmissible gastroenteritis virus nucleoprotein (1992) (29)
Effects of Infection with Transmissible Gastroenteritis Virus on Concomitant Immune Responses to Dietary and Injected Antigens (2004) (28)
Transmissible Gastroenteritis Coronavirus Genome Packaging Signal Is Located at the 5′ End of the Genome and Promotes Viral RNA Incorporation into Virions in a Replication-Independent Process (2013) (28)
Allosteric inhibition of aminopeptidase N functions related to tumor growth and virus infection (2017) (28)
The Coronaviridae now comprises two genera, coronavirus and torovirus: report of the Coronaviridae Study Group. (1993) (28)
Expression of swine transmissible gastroenteritis virus envelope antigens on the surface of infected cells: epitopes externally exposed (1990) (27)
The membrane M protein of the transmissible gastroenteritis coronavirus binds to the internal core through the carboxy-terminus. (2001) (27)
Coronaviruses and Arteriviruses (1998) (27)
Use of virus vectors for the expression in plants of active full‐length and single chain anti‐coronavirus antibodies (2006) (26)
Engineering Infectious cDNAs of Coronavirus as Bacterial Artificial Chromosomes (2014) (25)
Virulence factors in porcine coronaviruses and vaccine design (2016) (25)
In vitro and in vivo expression of foreign genes by transmissible gastroenteritis coronavirus-derived minigenomes. (2002) (25)
Isolation of sequences from a random-sequence expression library that mimic viral epitopes (1992) (23)
Antigenic modules in the N-terminal S1 region of the transmissible gastroenteritis virus spike protein. (2011) (22)
A continuous epitope from transmissible gastroenteritis virus S protein fused to E. coli heat-labile toxin B subunit expressed by attenuated Salmonella induces serum and secretory immunity (1996) (22)
S1 Subunit of Spike Protein from a Current Highly Virulent Porcine Epidemic Diarrhea Virus Is an Important Determinant of Virulence in Piglets (2018) (22)
N-acetylneuraminic acid plays a critical role for the haemagglutinating activity of avian infectious bronchitis virus and porcine transmissible gastroenteritis virus. (1993) (21)
An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern (2022) (21)
Cholesterol is important for a post-adsorption step in the entry process of transmissible gastroenteritis virus (2010) (21)
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19 (2022) (19)
Transmissible Gastroenteritis Coronavirus RNA-Dependent RNA Polymerase and Nonstructural Proteins 2, 3, and 8 Are Incorporated into Viral Particles (2011) (19)
A Point Mutation within the Replicase Gene Differentially Affects Coronavirus Genome versus Minigenome Replication (2005) (19)
Recombinant Chimeric Transmissible Gastroenteritis Virus (TGEV)—Porcine Epidemic Diarrhea Virus (PEDV) Virus Provides Protection against Virulent PEDV (2019) (19)
RNA virus replication, transcription and recombination (2011) (18)
Gene N Proximal and Distal RNA Motifs Regulate Coronavirus Nucleocapsid mRNA Transcription (2011) (18)
Characterization of transmissible gastroenteritis coronavirus S protein expression products in avirulent S. typhimurium Δcya Δcrp: persistence, stability and immune response in swine (1996) (18)
African Swine Fever virus. Brief review. (1983) (17)
Inter-specific analysis of Drosophila alcohol dehydrogenase by an immunoenzymatic assay using monoclonal antibodies. (1989) (17)
Analysis of the sialic acid-binding activity of the transmissible gastroenteritis virus. (1995) (16)
Studying Human Pathogens in Animal Models: Fine Tuning the Humanized Mouse (2005) (15)
The replication of a mouse adapted SARS-CoV in a mouse cell line stably expressing the murine SARS-CoV receptor mACE2 efficiently induces the expression of proinflammatory cytokines (2013) (15)
Revision of the taxonomy of theCoronavirus, Torovirus andArterivirus genera (1994) (14)
Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP 3 in fl ammasome (2015) (14)
Evolution and tropism of transmissible gastroenteritis coronavirus. (1993) (14)
Identification of a Gamma Interferon-Activated Inhibitor of Translation-Like RNA Motif at the 3′ End of the Transmissible Gastroenteritis Coronavirus Genome Modulating Innate Immune Response (2015) (14)
Transmissible gastroenteritis virus (TGEV)-based vectors with engineered murine tropism express the rotavirus VP7 protein and immunize mice against rotavirus (2010) (14)
Linear neutralizing epitopes on the peplomer protein of coronaviruses. (1990) (14)
Biochemical Aspects of Coronavirus Replication (2006) (14)
Resistance of cultures of normal T cells to infection with murine type C viruses (1981) (14)
Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory Pathology (2022) (14)
Nature of the Virus Associated with Endemic Balkan Nephropathy (2002) (13)
Minimum Determinants of Transmissible Gastroenteritis Virus Enteric Tropism Are Located in the N-Terminus of Spike Protein (2019) (13)
Science, not speculation, is essential to determine how SARS-CoV-2 reached humans (2021) (13)
T cell recognition of Moloney sarcoma virus proteins during tumor regression. I. Lack of a requirement for macrophages and the role of blastogenic factors in T cell proliferation. (1981) (13)
Role of transcription regulatory sequence in regulation of gene expression and replication of porcine reproductive and respiratory syndrome virus (2017) (13)
Nidovirales (2008) (13)
The immune response to C-type viruses and its potential role in leukemogenesis. (1982) (13)
Location of antigenic sites of the S-glycoprotein of transmissible gastroenteritis virus and their conservation in coronaviruses. (1990) (12)
A conserved coronavirus epitope, critical in virus neutralization, mimicked by internal-image monoclonal anti-idiotypic antibodies (1991) (12)
Molecular characterization of a Chinese vaccine strain of transmissible gastroenteritis virus: mutations that may contribute to attenuation (2010) (12)
Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories (2021) (11)
Synthesis of African swine fever (ASF) virus-specific antibodies in vitro in a porcine leucocyte system. (1987) (11)
Lactogenic immunity in transgenic mice producing recombinant antibodies neutralizing coronavirus. (1998) (10)
Isolation of cross-reactive monoclonal antibodies against divergent human coronaviruses that delineate a conserved and vulnerable site on the spike protein (2020) (10)
Recombinant dimeric small immunoproteins neutralize transmissible gastroenteritis virus infectivity efficiently in vitro and confer passive immunity in vivo. (2007) (10)
Engineering Infectious cDNAs of Coronavirus as Bacterial Artificial Chromosomes (2007) (9)
Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice (2020) (9)
Recombinant Live Vaccines to Protect Against the Severe Acute Respiratory Syndrome Coronavirus (2010) (9)
Genetically Engineered Live-Attenuated Middle East Respiratory Syndrome Coronavirus Viruses Confer Full Protection against Lethal Infection (2021) (9)
Virus-based vectors for gene expression in mammalian cells: Coronavirus (2003) (8)
Monoclonal antibodies to the envelope proteins of Moloney leukemia virus: characterization of recombinant viruses. (1980) (8)
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalization. (2021) (8)
Induction of transmissible gastroenteritis coronavirus-neutralizing antibodies in vitro by virus-specific T helper cell hybridomas. (1989) (8)
Identification of Essential Genes as a Strategy to Select a Sars Candidate Vaccine Using a SARS-CoV Infectious cDNA (2006) (7)
Immunopurification applied to the study of virus protein composition and encapsidation (2004) (7)
A multiplex antigen microarray for simultaneous IgG and IgM detection against SARS‐CoV‐2 reveals higher seroprevalence than reported (2021) (7)
Rapid differentiation of vaccine strain and Chinese field strains of transmissible gastroenteritis virus by restriction fragment length polymorphism of the N gene (2010) (7)
Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice (2021) (7)
Antigenic structures stably expressed by recombinant TGEV-derived vectors (2014) (7)
T cell recognition of Moloney sarcoma virus proteins. II. Phenotypes of the different lymphocyte subpopulations producing and responding to blastogenic factors and their relative frequencies during tumor regression. (1981) (6)
Characterization of a unique defective type C virus associated with a Moloney leukemia virus-induced splenic T-cell lymphoma cell line (1980) (6)
Immunogenic characterization and epitope mapping of transmissible gastroenteritis virus RNA dependent RNA polymerase (2011) (6)
Construction of a recombinant adenovirus for the expression of the glycoprotein S antigen of porcine respiratory coronavirus. (1993) (6)
Structure and intracellular assembly of the transmissible gastroenteritis coronavirus. (1998) (6)
Gas-liquid chromatography of amino acids in the blood of Wistar rats with Walker 256 carcinoma. (1971) (6)
The deubiquitinating activity of Middle East respiratory syndrome coronavirus papain-like protease delays the innate immune response and enhances virulence in a mouse model (2019) (6)
Cloning of a transmissible gastroenteritis coronavirus full-length cDNA. (2001) (5)
Reprint of: Coronavirus reverse genetic systems: Infectious clones and replicons☆ (2014) (5)
Progress towards the construction of a transmissible gastroenteritis coronavirus self-replicating RNA using a two-layer expression system. (1998) (5)
Tropism and immunoprotection in transmissible gastroenteritis coronaviruses. (1995) (5)
Molecular bases of tropism in the PUR46 cluster of transmissible gastroenteritis coronaviruses. (1995) (5)
SARS-CoV-2 Point Mutation and Deletion Spectra and Their Association with Different Disease Outcomes (2022) (4)
MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity (2021) (4)
P136 Combined action of type I and type III IFN restricts initial replication of SARS-coronavirus in the lung but fails to inhibit systemic virus spread (2012) (4)
Critical epitopes in transmissible gastroenteritis virus neutralization (1986) (4)
SARS-CoV-2 Mutant Spectra at Different Depth Levels Reveal an Overwhelming Abundance of Low Frequency Mutations (2022) (4)
Methods for preparation of low abundance glycoproteins from mammalian cell supernatants☆ (2006) (3)
The spike protein of transmissible gastroenteritis coronavirus controls the tropism of pseudorecombinant virions engineered using synthetic minigenomes. (1998) (3)
Isolation of hemagglutination-defective mutants for the analysis of the sialic acid binding activity of transmissible gastroenteritis virus. (1998) (3)
Induction of transmissible gastroenteritis coronavirus specific immune responses using vectors with enteric tropism. (1995) (3)
Expression of transcriptional units using transmissible gastroenteritis coronavirus derived minigenomes and full-length cDNA clones. (2001) (3)
New strategies in the development of PRRS vaccines. Subunit vaccines and self-limiting vectors, based on defective coronaviruses (2000) (3)
Viral PDZ Binding Motifs Influence Cell Behavior Through the Interaction with Cellular Proteins Containing PDZ Domains. (2021) (3)
Vaccines for Severe Acute Respiratory Syndrome Virus and Other Coronaviruses (2008) (3)
Structure and encapsidation of transmissible gastroenteritis coronavirus (TGEV) defective interfering genomes. (1995) (3)
Detection of SARS-CoV-2 in a dog with hemorrhagic diarrhea (2022) (3)
SARS-CoV-2-Mediated Lung Edema and Replication Are Diminished by Cystic Fibrosis Transmembrane Conductance Regulator Modulators (2023) (3)
Generation of a DNA-Launched Reporter Replicon Based on Dengue Virus Type 2 as a Multipurpose Platform (2017) (2)
Regulation of Coronavirus Transcription: Viral and Cellular Proteins Interacting with Transcription-Regulating Sequences (2006) (2)
MERS-CoV ORF4b is a virulence factor involved in the inflammatory pathology induced in the lungs of mice (2022) (2)
Interference with virus and bacteria replication by the tissue specific expression of antibodies and interfering molecules. (1999) (2)
On Channel Activity of Synthetic Peptides Derived from Severe and Acute Respiratory Syndrome Coronavirus (SARS-CoV) E Protein (2012) (2)
Revised nomenclature for coronavirus structural proteins, mRNAs and genes. (1990) (2)
RNA-Affinity Chromatography (2013) (1)
Suitability of transiently expressed antibodies for clinical studies: product quality consistency at different production scales (2022) (1)
Pulsed-Xenon Ultraviolet Light Highly Inactivates Human Coronaviruses on Solid Surfaces, Particularly SARS-CoV-2 (2022) (1)
SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice (2023) (1)
Interference of coronavirus infection by expression of IgG or IgA virus neutralizing antibodies. (1998) (1)
Nature of viruses and pandemics: Coronaviruses (2022) (1)
Development of a SARS- CoV-2 vaccine based in non- infective replicons (2021) (1)
Ion Channels Formed by SARS Coronavirus Envelope Protein: Lipid Regulation of Conductance and Selectivity (2013) (1)
Coronavirus derived expression systems. Progress and problems. (2001) (1)
Induction of an immune response to transmissible gastroenteritis coronavirus using vectors with enteric tropism. (1993) (1)
Genomic and antigenic variation of African swine fever virus (1986) (1)
Enveloped, Positive-Strand RNA Viruses (Nidovirales) (2008) (1)
Reverse Genetics with a Full-Length Infectious cDNA Clone of Bovine Torovirus (2020) (1)
Cytoplasmic ribonucleoprotein complexes, RNA helicases and coronavirus infection (2022) (0)
Crystal structure of the spike receptor binding domain of a porcine respiratory coronavirus in complex with the pig aminopeptidase N ectodomain (2012) (0)
Atypical Mutational Spectrum of SARS-CoV-2 Replicating in the Presence of Ribavirin (2023) (0)
Dextran sulfate from Leuconostoc mesenteroides B512F exerts potent antiviral activity against SARS-CoV-2 in vitro and in vivo (2023) (0)
NOTES Severe Acute Respiratory Syndrome Coronavirus Protein 6 Is Required for Optimal Replication (cid:1) (2009) (0)
Foreword (2015) (0)
Virus Research. Nidoviruses I. Foreword. (2014) (0)
CORONAVIRUS RNA ACCUMULATION LEVELS AND RELOCALIZES 2 VIRAL RNAs TO NOVEL CYTOPLASMIC DOMAINS DIFFERENT FROM 3 (2011) (0)
Gene expression, virulence and vaccine development in coronaviruses (2008) (0)
SARS-CoV-2 Point Mutation and Deletion Spectra, and Their Association with Different Disease Outcome (2022) (0)
Title: Induction of Cross-Protective Immunity Without Exposure to Live PRRSV-NPB #07-112 Investigator: (2009) (0)
recombinant adenoviruses expressing virus antigens porcine transmissible gastroenteritis (TGEV) and their use in the formation of vaccines. (1995) (0)
Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase (2023) (0)
Differential role of N-Terminal Polyprotein Processing in Coronavirus Genome Replication and Minigenome Amplification (2006) (0)
Erratum to: Role of transcription regulatory sequence in regulation of gene expression and replication of porcine reproductive and respiratory syndrome virus (2017) (0)
Cross-Links inAfrican SwineFeverVirusDNA (1979) (0)
PLOS Pathogens 2017 Reviewer and Editorial Board Thank You (2018) (0)
Contribution to pathogenesis of accessory proteins of deadly human coronaviruses (2023) (0)
Crystal structure of a TGEV coronavirus Spike fragment in complex with the TGEV neutralizing monoclonal antibody 1AF10 (2012) (0)
Protection against Middle East respiratory syndrome coronavirus infection by immunization with genetically engineered liveattenuated viruses. (2018) (0)
Interference with viral infection by transgenesis or tissue specific expression. (2001) (0)
Complete protection against SARS-CoV-mediated lethal respiratory disease in aged mice 1 by immunization with a mouse adapted virus deleted in E protein 2 3 (2013) (0)
A strategy for the generation of an infectious transmissible gastroenteritis coronavirus from cloned cDNA. (2001) (0)
Porcine gastroenteric viruses: pathogenesis and protection (2016) (0)
Title : Induction Of Cross-Protective Immunity Without Exposure To Live PRRSV-NPB # 08-197 (2010) (0)
Mucosa-specific expression of foreign genes by recombinant procine coronaviruses (2003) (0)
Foreword (2014) (0)
Relevance of SARS-CoV E Protein Ion Channel Activity in Virus Pathogenesis (2015) (0)
Towards a novel Coronavirus-based vector vaccine: studies on biosafety in piglets (2005) (0)
Tropism Studies of the Role of ORF 3 abc in Viral Cell Infectious Peritonitis Virus Strain DF-2 and Molecular Characterization of Feline (2012) (0)
Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2 (2023) (0)
CHARACTERIZATION OF CELLULAR INTERACTIONS WITH BLASTOGENIC FACTOR(S) IN ANTIGEN-SPECIFIC LYMPHOPROLIFERATIVE RESPONSES (1981) (0)
Virus Research. Foreword. Nidoviruses II. (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Luis Enjuanes?

Luis Enjuanes is affiliated with the following schools:

University of Marburg
University of Bristol
University of Valencia
University of Geneva
University of Barcelona
Autonomous University of Madrid

Luis Enjuanes's Academic­Influence.com Rankings

Luis Enjuanes's Degrees

Why Is Luis Enjuanes Influential?

Luis Enjuanes's Published Works

Published Works

What Schools Are Affiliated With Luis Enjuanes?

Luis Enjuanes's AcademicInfluence.com Rankings